Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05024318
Title NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma (NAPSTER)
Acronym NAPSTER
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Princess Alexandra Hospital RECRUITING Woolloongabba Queensland 4102 Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Victoria 3000 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field